About 64% of the global population under age 50 has HSV-1, the virus responsible for most oral herpes infections. That’s roughly 3.8 billion people worldwide, based on the most recent WHO estimates from 2020. In the United States, the rate is lower and has been declining: about 48% of Americans aged 14 to 49 tested positive for HSV-1 antibodies in the most recent national survey.
Most people with the virus never get a visible cold sore. The majority of HSV-1 infections are completely asymptomatic, meaning billions of people carry the virus without knowing it.
Global Numbers vs. the United States
The gap between worldwide and U.S. prevalence is significant. Globally, nearly two out of three people under 50 carry HSV-1. In developing regions, infection rates tend to be higher because the virus spreads easily through casual contact in childhood, particularly in crowded households or communities with less access to hygiene infrastructure.
In the U.S., the picture looks different. CDC data from the National Health and Nutrition Examination Survey (NHANES) shows that HSV-1 prevalence among 14- to 49-year-olds dropped from 59.4% in 1999–2000 to 48.1% in 2015–2016. That’s an 11-percentage-point decline in less than two decades. The trend held across all racial and ethnic groups tracked in the survey.
Why Rates Are Dropping in Younger Americans
The decline likely reflects improved hygiene practices and changes in how families and children interact. HSV-1 has traditionally been picked up in early childhood through kisses from relatives, shared utensils, or close play with other kids. As household sizes have shrunk, hygiene awareness has increased, and fewer adults share cups or eating utensils with children, fewer kids get exposed early.
This sounds like good news, and in one sense it is. But there’s a counterintuitive consequence: people who don’t catch HSV-1 as children have no antibodies against it. When they encounter the virus later, often through kissing or oral sex as teenagers or young adults, they’re more vulnerable to genital HSV-1 infections. About 10% of all HSV-1 infections globally (376 million cases) are genital rather than oral, and that proportion appears to be growing in countries where childhood infection rates have fallen.
Differences by Race and Ethnicity
HSV-1 prevalence varies substantially across demographic groups in the U.S. In the 2015–2016 NHANES data, 36.9% of non-Hispanic white Americans aged 14 to 49 tested positive, compared to 58.8% of non-Hispanic Black Americans and 71.7% of Mexican-American participants. These disparities are closely tied to socioeconomic factors like household density and neighborhood conditions rather than biological differences. Every group saw a decline over the survey period, but the gaps between groups persisted.
Most People Never Get a Cold Sore
One of the most common misunderstandings about oral herpes is that carrying the virus means getting cold sores. The reality is that the majority of people with HSV-1 are completely asymptomatic. They test positive for antibodies, meaning their immune system has encountered the virus, but they’ve never had a blister on or around their mouth.
Among those who do get symptoms, outbreaks typically become less frequent over time. A first episode tends to be the most noticeable, sometimes involving multiple sores, swollen gums, or flu-like symptoms. Recurrences, if they happen at all, are usually milder: a single sore that heals within a week or two. Common triggers for recurrences include stress, illness, sun exposure, and fatigue.
Even without visible sores, the virus can occasionally shed from the skin around the mouth. This is called asymptomatic shedding, and it’s why HSV-1 spreads so efficiently. A person with no symptoms can still pass the virus through a kiss or by sharing a drink, though the risk is highest during an active outbreak.
How HSV-1 Testing Works
If you’ve never had a cold sore and want to know your status, a blood test can check for HSV-1 antibodies. These tests look for proteins your immune system produces after encountering the virus. They can’t tell you where on your body the infection is (oral or genital) or when you were infected.
Accuracy varies by test. Some of the most commonly used automated blood tests for HSV-1 have sensitivity below 85%, meaning they miss more than 1 in 7 infections while correctly identifying negatives over 97% of the time. One widely used test platform showed a false positive rate of over 60% when the result was in the low-positive range (a weak positive signal). This means a low-positive HSV-1 blood test result is actually more likely to be wrong than right.
For this reason, routine HSV screening isn’t part of standard STI panels in the U.S. If you have a visible sore, a swab test taken directly from the lesion is far more reliable than a blood test. Blood testing is most useful when there’s a specific clinical reason, such as a partner with known herpes or recurrent symptoms that haven’t been diagnosed.
Living With Oral HSV-1
For the vast majority of people, oral herpes is a minor inconvenience at most. Cold sores are temporarily uncomfortable and can be cosmetically frustrating, but they heal on their own. Antiviral medications can shorten outbreaks by a day or two and reduce their frequency for people who get them often. These are available both as pills and topical creams.
The virus stays in your body for life, lying dormant in nerve cells near the base of the skull. Your immune system keeps it in check most of the time. Serious complications are rare and almost exclusively affect newborns (who can contract the virus during delivery), people with severely weakened immune systems, or in very rare cases, people experiencing their first infection who develop inflammation around the brain. For a healthy adult, carrying HSV-1 is one of the most common and least consequential viral infections there is.